Abstract
Chronic kidney disease (CKD) is a condition with an irreversible reduction in the number of functioning nephrons, which results in progressive and permanent deterioration in kidney function. There were numerous complications associated with CKD which include secondary hyperparathyroidism. Controlling elevated serum phosphorus levels and directly targeting suppression of intact parathyroid hormone (iPTH) production remain targets. This study aimed to evaluate the efficacy and safety of etelcalcetide in the treatment of secondary hyperparathyroidism in adult patients with CKD undergoing dialysis
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
